Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Phlebotomy × Endocrine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Sarcoma 1 NET 1 Myeloid 1 Genitourinary 1 Gastrointestinal 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 6 Everolimus 6 lanreotide 5 Temozolomide 5 anlotinib 4 Dexmedetomidine 4 surufatinib 3 Thyrotropin Alfa 3 Saline Solution 3 Injections 3 Cisplatin 3 Blood Specimen Collection 3 sintilimab 2 penpulimab 2 cabozantinib 2 Surgical Procedures, Operative 2 Sorafenib 2 Sodium Chloride 2 Rosiglitazone 2 Radiotherapy 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Nivolumab 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Lymph Node Excision 2 Liquid Biopsy 2 Fluorodeoxyglucose F18 2 Capecitabine 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03130205 2017-08-25

PROGRESS

Uppsala University

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡